Matches in SemOpenAlex for { <https://semopenalex.org/work/W2586941494> ?p ?o ?g. }
Showing items 1 to 98 of
98
with 100 items per page.
- W2586941494 abstract "Abstract Introduction: B-cell chronic lymphocytic leukemia CLL is characterized by an accumulation of mature, non functional B cells. We and others have shown that WNT/β-catenin (CTNNB1) signaling appears to be constitutively activated in these cells. Furthermore, it is already long known that several compounds related to the non-steroidal antiinflamnmatory drugs (NSAID) can inhibit CTNNB1 stability and/or function. However, so far clinical studies with such substances generated disappointing results which is likely to the fact that therapeutic plasma concentrations could not be reached without producing significant toxicities. Recently, nitric oxide donating derivatives of acetylic salicylic acid (NO-ASA) have been shown to be well tolerated in humans. In addition NO-ASA could disrupt complexation of CTNNB1 and TCF-4 in vitro, whereas the latter belongs to the transcription factors which posses a central function in mediating WNT signaling. The aim of our study was to evaluate whether the para- and meta-isomers of NO-ASA selectively induce apoptosis in CLL cells. Methods: Primary CLL cells as well as healthy peripheral blood monocytes (PBMC) were treated with varying concentrations of p- and m-NO-ASA for different time periods. Cytotoxicity was assessed by microscopic cell viability testing and an ATP assay. Induction of apoptosis was investigated by immunoblotting of PARP, caspases 3 and 9. Further, CTNNB1 protein amount was measured by immunoblotting and expression of WNT effector proteins like cyclin D1 (CCND1), C-MYC and LEF-1 was evaluated with immunoblot analysis as well. Results: The meta-isoform of NO-ASA did not have any effect on CLL cells whereas the para-isomer showed a selective cytotoxic effect. Mean lethal concentration (LC50) values were 4.83 μM and 4.64 μM in CLL cells, respectively. LC50 values for healthy controls were more than 25-fold higher. Immunoblot analysis revealed that p-NO-ASA cleaves PARP; caspase 3 and caspase 9, decreases CTNNB1 protein levels and downregulates WNT pathway target genes in a concentration dependent manner. Conclusion: Our findings show that the para- but not the meta-isomer of NO-ASA induces caspase-mediated apoptosis by inhibition of WNT signaling in CLL cells. NO-ASA, consisting of a traditional molecule of ASA where the NO moiety is covalently bound via a spacer, has been shown to exhibit a lower gastric toxicity than traditional NSAIDs. Therefore p-NO-ASA might be a valuable compound for the treatment of CLL. More investigations of the exact mechanism of action and the specific difference between the positional isomers are indicated." @default.
- W2586941494 created "2017-02-17" @default.
- W2586941494 creator A5012998953 @default.
- W2586941494 creator A5019049179 @default.
- W2586941494 creator A5036223201 @default.
- W2586941494 creator A5040644019 @default.
- W2586941494 creator A5043334730 @default.
- W2586941494 creator A5049255971 @default.
- W2586941494 creator A5052690464 @default.
- W2586941494 creator A5068698149 @default.
- W2586941494 creator A5076077834 @default.
- W2586941494 date "2008-11-16" @default.
- W2586941494 modified "2023-09-28" @default.
- W2586941494 title "The Para-Isomer of Nitric Oxide-Donating Acetylic Salicylic Acid (p-NO-ASA) Effectively Induces Cell Death in B-Cell Chronic Lymphocytic Leukemia (CLL) Cells at Low Micromolar Concentrations." @default.
- W2586941494 doi "https://doi.org/10.1182/blood.v112.11.1606.1606" @default.
- W2586941494 hasPublicationYear "2008" @default.
- W2586941494 type Work @default.
- W2586941494 sameAs 2586941494 @default.
- W2586941494 citedByCount "0" @default.
- W2586941494 crossrefType "journal-article" @default.
- W2586941494 hasAuthorship W2586941494A5012998953 @default.
- W2586941494 hasAuthorship W2586941494A5019049179 @default.
- W2586941494 hasAuthorship W2586941494A5036223201 @default.
- W2586941494 hasAuthorship W2586941494A5040644019 @default.
- W2586941494 hasAuthorship W2586941494A5043334730 @default.
- W2586941494 hasAuthorship W2586941494A5049255971 @default.
- W2586941494 hasAuthorship W2586941494A5052690464 @default.
- W2586941494 hasAuthorship W2586941494A5068698149 @default.
- W2586941494 hasAuthorship W2586941494A5076077834 @default.
- W2586941494 hasConcept C109316439 @default.
- W2586941494 hasConcept C137061746 @default.
- W2586941494 hasConcept C137620995 @default.
- W2586941494 hasConcept C153911025 @default.
- W2586941494 hasConcept C178790620 @default.
- W2586941494 hasConcept C185592680 @default.
- W2586941494 hasConcept C190283241 @default.
- W2586941494 hasConcept C199835354 @default.
- W2586941494 hasConcept C202751555 @default.
- W2586941494 hasConcept C203014093 @default.
- W2586941494 hasConcept C2777938653 @default.
- W2586941494 hasConcept C2778461978 @default.
- W2586941494 hasConcept C29537977 @default.
- W2586941494 hasConcept C31573885 @default.
- W2586941494 hasConcept C502942594 @default.
- W2586941494 hasConcept C519581460 @default.
- W2586941494 hasConcept C53227056 @default.
- W2586941494 hasConcept C55493867 @default.
- W2586941494 hasConcept C62478195 @default.
- W2586941494 hasConcept C86803240 @default.
- W2586941494 hasConcept C98424977 @default.
- W2586941494 hasConceptScore W2586941494C109316439 @default.
- W2586941494 hasConceptScore W2586941494C137061746 @default.
- W2586941494 hasConceptScore W2586941494C137620995 @default.
- W2586941494 hasConceptScore W2586941494C153911025 @default.
- W2586941494 hasConceptScore W2586941494C178790620 @default.
- W2586941494 hasConceptScore W2586941494C185592680 @default.
- W2586941494 hasConceptScore W2586941494C190283241 @default.
- W2586941494 hasConceptScore W2586941494C199835354 @default.
- W2586941494 hasConceptScore W2586941494C202751555 @default.
- W2586941494 hasConceptScore W2586941494C203014093 @default.
- W2586941494 hasConceptScore W2586941494C2777938653 @default.
- W2586941494 hasConceptScore W2586941494C2778461978 @default.
- W2586941494 hasConceptScore W2586941494C29537977 @default.
- W2586941494 hasConceptScore W2586941494C31573885 @default.
- W2586941494 hasConceptScore W2586941494C502942594 @default.
- W2586941494 hasConceptScore W2586941494C519581460 @default.
- W2586941494 hasConceptScore W2586941494C53227056 @default.
- W2586941494 hasConceptScore W2586941494C55493867 @default.
- W2586941494 hasConceptScore W2586941494C62478195 @default.
- W2586941494 hasConceptScore W2586941494C86803240 @default.
- W2586941494 hasConceptScore W2586941494C98424977 @default.
- W2586941494 hasLocation W25869414941 @default.
- W2586941494 hasOpenAccess W2586941494 @default.
- W2586941494 hasPrimaryLocation W25869414941 @default.
- W2586941494 hasRelatedWork W1861055009 @default.
- W2586941494 hasRelatedWork W1981965146 @default.
- W2586941494 hasRelatedWork W1987594535 @default.
- W2586941494 hasRelatedWork W2021089774 @default.
- W2586941494 hasRelatedWork W2031611922 @default.
- W2586941494 hasRelatedWork W2059706503 @default.
- W2586941494 hasRelatedWork W2098971766 @default.
- W2586941494 hasRelatedWork W2142369892 @default.
- W2586941494 hasRelatedWork W2335526988 @default.
- W2586941494 hasRelatedWork W2365861741 @default.
- W2586941494 hasRelatedWork W2473499075 @default.
- W2586941494 hasRelatedWork W2535054682 @default.
- W2586941494 hasRelatedWork W2535346982 @default.
- W2586941494 hasRelatedWork W2564864293 @default.
- W2586941494 hasRelatedWork W2568790842 @default.
- W2586941494 hasRelatedWork W2625395175 @default.
- W2586941494 hasRelatedWork W2794028627 @default.
- W2586941494 hasRelatedWork W2997226872 @default.
- W2586941494 hasRelatedWork W3029857048 @default.
- W2586941494 hasRelatedWork W2767278237 @default.
- W2586941494 isParatext "false" @default.
- W2586941494 isRetracted "false" @default.
- W2586941494 magId "2586941494" @default.
- W2586941494 workType "article" @default.